Navigation Links
PMD Healthcare Announces Support for Actions that People with Asthma or COPD Should Take to Prevent the Flu
Date:2/21/2013

Allentown, PA (PRWEB) February 21, 2013

Many healthcare professionals consider the current flu epidemic the worst in years. It has posed a severe threat to people with chronic lung conditions like asthma and COPD who are particularly vulnerable to the virus.

However, healthcare professionals now agree that five critical actions can help prevent flu transmission: monitoring breathing, reporting any changes in lung health to the doctor, staying on track with prescribed medications, getting a flu vaccine, and washing hands thoroughly.

As the world’s first personal spirometer, Spiro PD supports four of these five critical steps to prevent flu transmission.

Spiro PD empowers people with respiratory conditions to easily and accurately monitor their breathing any time and anywhere: at home, work, school, play, or while traveling.

Spiro PD lets patients quickly and simply upload their lung health data and share it with their doctor. So, if necessary, the doctor can easily make changes to the patient’s treatment in a timely manner.

Spiro PD enhances medication adherence by letting patients set alarms reminding them when to take their medicine, plus when to test their lung function and do breathing exercises.

The US Preventive Services Task Force (USPTF) has stated that evidence suggests influenza vaccination reduces COPD exacerbations. The USPTF, for a number of years, also has theorized that spirometry may help increase flu vaccination rates among people with COPD, asthma, emphysema, cystic fibrosis, or a lung transplant by helping them closely monitor their lung health.

Wayne Meng, Founder, Chief Executive Officer, and President of PMD Healthcare, the maker of Spiro PD, says, “It is important that people with chronic respiratory conditions do everything they can to fight the flu. Spiro PD gives people with COPD, asthma, and other breathing conditions new power in their fight.”

In the United States, the cold and flu season is considered October through May, usually peaking in February.(1,2) Each year, colds and flu usually account for 200,000 hospitalizations and 41,000 deaths in this country.(3) People with respiratory conditions, including asthma, COPD, bronchitis, emphysema, cystic fibrosis, and a lung transplant, are particularly susceptible, and can develop life-threatening complications including pneumonias and acute respiratory distress syndrome.(4)

For more information about all the advantages that the Spiro PD Personal Spirometer offers people with respiratory conditions, please visit http://www.SpiroPD.com.

About Spiro PD
“Spiro" stands for spirometer, a device used to measure air entering and leaving the lungs; "PD" stands for personal device. Spiro PD is the first personal spirometer that enables people with lung diseases – COPD, asthma, CF, and lung transplants – to easily and accurately monitor their breathing anytime and anywhere.

Spiro PD tracks lung function trends to help patients anticipate and prevent respiratory disease exacerbations, which helps reduce expensive emergency room visits and hospital stays. According to a study conducted at Johns Hopkins University, home spirometry detected decreased lung function 16 days before patients felt symptoms and sought medical care.(5)

Spiro PD enhances medication adherence. The medication alarm helps patients remember to take their medicine. The medication history provides a time stamp to show doctors that patients have been following their therapy.

Spiro PD also allows patients to set alarms reminding them to perform spirometry tests and do breathing exercises. Plus, patients can quickly upload data to their computer and share it with their doctor.

Spiro PD is cleared by the FDA for home use by the patient to test lung function in children, adolescents, and adults. Many insurance companies cover the cost of Spiro PD.

Spiro PD meets American Thoracic Society (ATS) and European Respiratory Society (ERS) standards. Spiro PD is also certified with the CE mark for the European Union (EU).

For more information, visit http://www.SpiroPD.com.

About PMD Healthcare, Inc.
PMD Healthcare, manufacturer of Spiro PD, is dedicated to creating innovative, easy-to-use, portable, and affordable personal medical devices that empower people worldwide to improve their healthcare and quality of life. For more information about PMD Healthcare and Spiro PD, please visit http://www.SpiroPD.com.

1. CDC Questions and Answers 2010-01-27, Retrieved 2010-08-10.
2. CDC: The Flu Season. http://www.cdc.gov/flu/about/season/flu-season.htm. Retrieved 11-22-12.
3. Molinari, Ortega-Sanchez, Messonnier, Thompson, Wortley, Weintraub, Bridges. The annual impact of seasonal in?uenza in the US: Measuring disease burden and costs doi:10.1016/j.vaccine.2007.03.046 PMID 17544181.
4. Flu Season Overview North Carolina Immunization portal. Retrieved 11-22-12.
5. West NE, Boyle MP, Mogayzel PJ, Riekert KA, Lechtzin N. The ability of home spirometry and symptom monitoring to predict exacerbations in cystic fibrosis. Pediatric Pulmonology 2009; Vol. 34, S32 “Poster Session Abstract” poster 376.

Read the full story at http://www.prweb.com/releases/personalspirometer/personalspirometry/prweb10431368.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Weill Cornell Medical College establishes Center for Healthcare Informatics and Policy
2. Coral Calcium Company Announces New Offer Amidst Supreme Court Healthcare Decisions
3. Healthcare researchers recognized at SingHealth Duke-NUS Scientific Congress 2012
4. Daily disinfection of isolation rooms reduces contamination of healthcare workers hands
5. Health inequalities could be reduced by more effective healthcare, says new study
6. Healthcare ethics consultants share lessons learned
7. Kessler Foundation stroke expert receives $145,000 grant from Healthcare Foundation of New Jersey
8. Social environmental factors affect rehospitalization risk in home healthcare patients
9. TGen, Scottsdale Healthcare lead worldwide study of new drug for patients with pancreatic cancer
10. CWRU dental and nursing students collaborate for one-stop healthcare
11. University Hospitals & Philips Healthcare to showcase imaging technology at Cleveland Medical Mart
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... , ... December 08, 2016 , ... ... Research Institute (WCRI) officially opened registration today for its 33rd Annual Issues ... Boston, MA . , The theme of the conference is “Persistent Challenges and ...
(Date:12/8/2016)... Pa. (PRWEB) , ... December 08, 2016 , ... ... Medicine Southern Chester County, a Property owned by an affiliate of Seavest, has ... square foot Penn Medicine Southern Chester County ambulatory care center (ACC) was named ...
(Date:12/8/2016)... ... December 08, 2016 , ... With the increasing demand for dental implants, the ... (WIYM) campaign to inform dentists and patients about the safety issues related to dental ... market in the U.S. is projected to reach $6.4 billion in 2018 with more ...
(Date:12/8/2016)... ... December 08, 2016 , ... ... access for customers and employees that are both engaging and easy to use. ... Smart Technology, the software company revealed today its plans to roll out new ...
(Date:12/8/2016)... ... December 08, 2016 , ... ... has been recognized for adherence to the highest standards of trauma, maternity, ... organizations, announced the center's president and CEO, Dr. Daniel Messina. , Among the ...
Breaking Medicine News(10 mins):
(Date:12/9/2016)... , Dec. 9, 2016   Hudes Laser ... December featuring the multi-wavelength Astanza Trinity laser and ... specializes in laser tattoo removal, IPL hair removal, ... ultrasound therapy. Hudes Laser Aesthetica is setting high ... and promises to deliver effective, long-lasting ...
(Date:12/9/2016)... OSAKA, Japan , Dec. 9, 2016 ... ; President & Representative Director, CEO: Dr. ... with amyotrophic lateral sclerosis (ALS) given edaravone intravenously in ... functional loss as measured by the ALS Functional Rating ... th International Symposium on ALS/MND in ...
(Date:12/9/2016)... 9, 2016  Axovant Sciences Ltd. (NYSE: ... focused on the treatment of dementia, today announced ... Phase 2b trial evaluating treatment with intepirdine (RVT-101), ... donepezil plus placebo in people with mild-to-moderate Alzheimer,s ... intepirdine to treatment was associated with reduced progression ...
Breaking Medicine Technology: